Research ExplorerJournalsANTIMICROB AGENTS CH Publications

ANTIMICROB AGENTS CH - Antimicrobial agents and chemotherapy

1 - 31 out of 31Page size: 50

Publications

  1. 2023

  2. Novel Synergies and Isolate Specificities in the Drug Interaction Landscape of Mycobacterium abscessus

    Van, N., Degefu, Y. N., Leus, P. A., Larkins-Ford, J., Klickstein, J., Maurer, F. P., Stone, D., Poonawala, H., Thorpe, C. M., Smith, T. C. & Aldridge, B. B., 18.07.2023, In: ANTIMICROB AGENTS CH. 67, 7, p. e00090-23

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  3. 2022

  4. Respiratory Syncytial Virus Two-Step Infection Screen Reveals Inhibitors of Early and Late Life Cycle Stages

    Sake, S. M., Kosch, C., Blockus, S., Haid, S., Gunesch, A. P., Zhang, X., Friesland, M., Trummer, S. B., Grethe, C., Kühnel, A., Rückert, J., Duprex, W. P., Huang, J., Rameix-Welti, M-A., Empting, M., Fischer, N., Hirsch, A. K. H., Schulz, T. F. & Pietschmann, T., 20.12.2022, In: ANTIMICROB AGENTS CH. 66, 12, e0103222.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  5. Pharmacokinetics of Nirmatrelvir and Ritonavir in COVID-19 Patients with End-Stage Renal Disease on Intermittent Hemodialysis

    Lingscheid, T., Kinzig, M., Krüger, A., Müller, N., Bölke, G., Tober-Lau, P., Münn, F., Kriedemann, H., Witzenrath, M., Sander, L. E., Sörgel, F. & Kurth, F., 15.11.2022, In: ANTIMICROB AGENTS CH. 66, 11, e0122922.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  6. 2021

  7. Impact of Dose, Duration, and Immune Status on Efficacy of Ultrashort Telacebec Regimens in Mouse Models of Buruli Ulcer

    Komm, O., Almeida, D. V., Converse, P. J., Omansen, T. F. & Nuermberger, E. L., 18.10.2021, In: ANTIMICROB AGENTS CH. 65, 11, e0141821.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  8. 2020

  9. Telacebec for Ultrashort Treatment of Buruli Ulcer in a Mouse Model

    Almeida, D. V., Converse, P. J., Omansen, T. F., Tyagi, S., Tasneen, R., Kim, J. & Nuermberger, E. L., 21.05.2020, In: ANTIMICROB AGENTS CH. 64, 6, p. e00259-20

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  10. 2019

  11. Oxazolidinones Can Replace Clarithromycin in Combination with Rifampin in a Mouse Model of Buruli Ulcer

    Almeida, D. V., Omansen, T. F., Li, S-Y., Lee, J., Grosset, J. H., Converse, P. J. & Nuermberger, E. L., 03.2019, In: ANTIMICROB AGENTS CH. 63, 3, p. e02171-18

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  12. High-Dose Rifamycins Enable Shorter Oral Treatment in a Murine Model of Mycobacterium ulcerans Disease

    Omansen, T. F., Almeida, D., Converse, P. J., Li, S-Y., Lee, J., Stienstra, Y., van der Werf, T., Grosset, J. H. & Nuermberger, E. L., 02.2019, In: ANTIMICROB AGENTS CH. 63, 2, p. e01478-18

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  13. Population Pharmacokinetics of Mefloquine Intermittent Preventive Treatment for Malaria in Pregnancy in Gabon

    Ramharter, M., Schwab, M., Mombo-Ngoma, G., Zoleko Manego, R., Akerey-Diop, D., Basra, A., Mackanga, J-R., Würbel, H., Wojtyniak, J-G., Gonzalez, R., Hofmann, U., Geditz, M., Matsiegui, P-B., Kremsner, P. G., Menendez, C., Kerb, R. & Lehr, T., 02.2019, In: ANTIMICROB AGENTS CH. 63, 2, p. e01113-18

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  14. 2018

  15. Reliable and Easy-To-Use Liquid Chromatography-Tandem Mass Spectrometry Assay for Quantification of Olorofim (F901318), a Novel Antifungal Drug, in Human Plasma and Serum

    Müller, C., Fietz, C., Koehler, P., Sibley, G., Nforbugwe, A. C. A., Streichert, T. & Wiesen, M. H. J., 11.2018, In: ANTIMICROB AGENTS CH. 62, 11

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  16. Impact of Clofazimine Dosing on Treatment Shortening of the First-Line Regimen in a Mouse Model of Tuberculosis

    Ammerman, N. C., Swanson, R. V., Bautista, E. M., Almeida, D. V., Saini, V., Omansen, T. F., Guo, H., Chang, Y. S., Li, S-Y., Tapley, A., Tasneen, R., Tyagi, S., Betoudji, F., Moodley, C., Ngcobo, B., Pillay, L., Bester, L. A., Singh, S. D., Chaisson, R. E., Nuermberger, E. & Grosset, J. H., 07.2018, In: ANTIMICROB AGENTS CH. 62, 7, p. e00636-18

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  17. Prospective Clinical Trial Assessing Species-Specific Efficacy of Artemether-Lumefantrine for the Treatment of Plasmodium malariae, Plasmodium ovale, and Mixed Plasmodium Malaria in Gabon

    Groger, M., Veletzky, L., Lalremruata, A., Cattaneo, C., Mischlinger, J., Zoleko-Manego, R., Endamne, L., Klicpera, A., Kim, J., Nguyen, T., Flohr, L., Remppis, J., Matsiegui, P-B., Adegnika, A. A., Agnandji, S. T., Kremsner, P. G., Mordmüller, B., Mombo-Ngoma, G. & Ramharter, M., 03.2018, In: ANTIMICROB AGENTS CH. 62, 3, p. e01758-17

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  18. 2014

  19. Lack of antimicrobial bactericidal activity in Mycobacterium abscessus

    Maurer, F. P., 07.2014, In: ANTIMICROB AGENTS CH. 58, 7, p. 3828-36 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  20. Pharmacokinetics of ganciclovir during continuous venovenous hemodiafiltration in critically ill patients

    Horvatits, T., Kitzberger, R., Drolz, A., Zauner, C., Jäger, W., Böhmdorfer, M., Kraff, S., Fritsch, A., Thalhammer, F., Fuhrmann, V. & Schenk, P., 01.01.2014, In: ANTIMICROB AGENTS CH. 58, 1, p. 94-101 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  21. 2013

  22. Antiviral effect, safety, and pharmacokinetics of five-day oral administration of Deleobuvir (BI 207127), an investigational hepatitis C virus RNA polymerase inhibitor, in patients with chronic hepatitis C

    Larrey, D., Lohse, A. W., Trepo, C., Bronowicki, J-P., Arastéh, K., Bourlière, M., Calleja, J. L., Stern, J. O., Nehmiz, G., Abdallah, N., Berger, K. L., Marquis, M., Steffgen, J., Kukolj, G. & BI 207127 Study Group, 01.10.2013, In: ANTIMICROB AGENTS CH. 57, 10, p. 4727-35 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  23. cyp51A-Based mechanisms of Aspergillus fumigatus azole drug resistance present in clinical samples from Germany

    Bader, O., Weig, M., Reichard, U., Lugert, R., Kuhns, M., Christner, M., Held, J., Peter, S., Schumacher, U., Buchheidt, D., Tintelnot, K., Groß, U. & MykoLabNet-D Partners, 01.08.2013, In: ANTIMICROB AGENTS CH. 57, 8, p. 3513-7 5 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  24. 2012

  25. Microbiological analysis of a prospective, randomized, double-blind trial comparing moxifloxacin and clindamycin in the treatment of odontogenic infiltrates and abscesses.

    Sobottka, I., Wegscheider, K., Balzer, O., Böger, R., Hallier, O., Giersdorf, I., Streichert, T., Haddad, M., Platzer, U. & Cachovan, G., 2012, In: ANTIMICROB AGENTS CH. 56, 5, p. 2565-2569 5.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  26. 2011

  27. Diphenylpyrazole-derived compounds increase survival time of mice after prion infection

    Leidel, F., Eiden, M., Geissen, M., Kretzschmar, H. A., Giese, A., Hirschberger, T., Tavan, P., Schätzl, H. M. & Groschup, M. H., 10.2011, In: ANTIMICROB AGENTS CH. 55, 10, p. 4774-4781 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  28. Comparative efficacy and safety of moxifloxacin and clindamycin in the treatment of odontogenic abscesses and inflammatory infiltrates: a phase II, double-blind, randomized trial.

    Cachovan, G., Böger, R., Giersdorf, I., Hallier, O., Streichert, T., Haddad, M., Platzer, U., Schön, G., Wegscheider, K. & Sobottka, I., 2011, In: ANTIMICROB AGENTS CH. 55, 3, p. 1142-1147 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  29. 2010

  30. No evidence for induction of ABC transporters in peripheral blood mononuclear cells in humans after 14 days of efavirenz treatment.

    Burhenne, J., Matthée, A-K., Pasáková, I., Röder, C., Heinrich, T., Haefeli, W. E., Mikus, G. & Weiss, J., 2010, In: ANTIMICROB AGENTS CH. 54, 10, p. 4185-4191 10.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  31. ramR mutations in clinical isolates of Klebsiella pneumoniae with reduced susceptibility to tigecycline.

    Hentschke, M., Wolters, M., Sobottka, I., Rohde, H. & Aepfelbacher, M., 2010, In: ANTIMICROB AGENTS CH. 54, 6, p. 2720-2723 6.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  32. 2009

  33. Combined ramR mutation and presence of a Tn1721-associated tet(A) variant in a clinical isolate of Salmonella enterica Serovar Hadar resistant to Tigecycline.

    Hentschke, M., Christner, M., Sobottka, I., Aepfelbacher, M. & Rohde, H., 2009, In: ANTIMICROB AGENTS CH.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  34. 2008

  35. Simvastatin treatment shows no effect on the incidence of cerebral malaria or parasitemia during experimental malaria

    Kobbe, R., Schreiber, N., May, J. & Jacobs, T., 01.04.2008, In: ANTIMICROB AGENTS CH. 52, 4, p. 1583-4 2 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  36. 2007

  37. Intermittent preventive treatment in infants as a means of malaria control: a randomized, double-blind, placebo-controlled trial in northern Ghana.

    Mockenhaupt, F. P., Reither, K., Zanger, P., Roepcke, F., Danquah, I., Saad, E., Ziniel, P., Dzisi, S. Y., Frempong, M., Agana-Nsiire, P., Amoo-Sakyi, F., Otchwemah, R., Cramer, J., Anemana, S. D., Dietz, E. & Bienzle, U., 2007, In: ANTIMICROB AGENTS CH. 51, 9, p. 3273-3281 9.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  38. Large-scale surveillance of Plasmodium falciparum crt(K76T) in northern Ghana.

    Ehrhardt, S., Eggelte, T. A., Kaiser, S., Adjei, L., Burchard, G-D., Anemana, S. D., Bienzle, U. & Mockenhaupt, F. P., 2007, In: ANTIMICROB AGENTS CH. 51, 9, p. 3407-3409 9.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  39. Strong and selective inhibitors of hepatitis B virus replication among novel N4-hydroxy- and 5-methyl-beta-L-deoxycytidine analogues.

    Matthes, E., Funk, A., Krahn, I., Gaertner, K., von Janta-Lipinski, M., Lin, L., Will, H. & Sirma, H., 2007, In: ANTIMICROB AGENTS CH. 51, 7, p. 2523-2530 7.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  40. 2005

  41. mecA is not involved in the sigmaB-dependent switch of the expression phenotype of methicillin resistance in Staphylococcus epidermidis

    Knobloch, J. K-M., Jäger, S., Huck, J., Horstkotte, M. A. & Mack, D., 03.2005, In: ANTIMICROB AGENTS CH. 49, 3, p. 1216-9 4 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  42. 2002

  43. Characterization of imidazo[4,5-d]pyridazine nucleosides as modulators of unwinding reaction mediated by West Nile virus nucleoside triphosphatase/helicase: evidence for activity on the level of substrate and/or enzyme.

    Borowski, P., Lang, M., Haag, A., Schmitz, H., Choe, J., Huan-Ming, C. & Hosmane Ramachandra, S., 2002, In: ANTIMICROB AGENTS CH. 46, 5, p. 1231-1239 5.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  44. Differential expression of methicillin resistance by different biofilm-negative Staphylococcus epidermidis transposon mutant classes.

    Mack, D., Sabottke, A., Dobinsky, S., Rohde, H., Horstkotte, M. A. & Knobloch, J. K-M., 2002, In: ANTIMICROB AGENTS CH. 46, 1, p. 178-183 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  45. In vitro activity of moxifloxacin against bacteria isolated from odontogenic abscesses.

    Sobottka, I., Cachovan, G., Stürenburg, E., Ahlers, O., Laufs, R., Platzer, U. & Mack, D., 2002, In: ANTIMICROB AGENTS CH. 46, 12, p. 4019-4021 12.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  46. 2000

  47. Concentrations of chloroquine and malaria parasites in blood in Nigerian children.

    Mockenhaupt, F. P., May, J., Bergqvist, Y., Ademowo, O. G., Olumese, P. E., Falusi, A. G., Großterlinden, L. G., Meyer, C. G. & Bienzle, U., 2000, In: ANTIMICROB AGENTS CH. 44, 4, p. 835-839 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  48. 1998

  49. Immunomodulating properties of the antibiotic novobiocin in human monocytes.

    Lührmann, A., Thölke, J., Behn, I., Schumann, J., Tiegs, G. & Hauschildt, S., 1998, In: ANTIMICROB AGENTS CH. 42, 8, p. 1911-1916 8.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review